A new oral weight-loss drug from Pfizer could be more effective than the popular Ozempic injection, based on clinical trial results.

Share:
More In Business
Bloomingdale's Names New CEO
Bloomingdale's named Olivier Bron its new chief executive, replacing Tony Spring, who will become CEO of Macy's.
Load More